 | • レポートコード：MR2211M-4379 • 出版社/出版日：Market Monitor Global / 2022年5月 • レポート形態：英文、PDF、69ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：医療装置 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥721,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、早期がん検診製品のグローバル市場規模と予測を記載しています。・早期がん検診製品のグローバル市場：売上、2017年-2022年、2023年-2028年 ・早期がん検診製品のグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 早期がん検診製品のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「単一がん」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 早期がん検診製品のグローバル主要企業は、EXACT Sciences Corporation、 Epigenomics AG、 Abbott Laboratories、 Genomictree、 oncgnostics GmbH、 Qiagen、 New Horizon Health、 iStat Biomedical Co., Ltd、 GRAIL、 Laboratory For Advanced Medicine Inc、 Genetron Health、 Berry Oncologyなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、早期がん検診製品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の早期がん検診製品市場：タイプ別、2017年-2022年、2023年-2028年 世界の早期がん検診製品市場：タイプ別市場シェア、2021年 ・単一がん、汎がん 世界の早期がん検診製品市場：用途別、2017年-2022年、2023年-2028年 世界の早期がん検診製品市場：用途別市場シェア、2021年 ・病院、クリニック、その他 世界の早期がん検診製品市場：地域・国別、2017年-2022年、2023年-2028年 世界の早期がん検診製品市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における早期がん検診製品のグローバル売上、2017年-2022年 ・主要企業における早期がん検診製品のグローバル売上シェア、2021年 ・主要企業における早期がん検診製品のグローバル販売量、2017年-2022年 ・主要企業における早期がん検診製品のグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 EXACT Sciences Corporation、 Epigenomics AG、 Abbott Laboratories、 Genomictree、 oncgnostics GmbH、 Qiagen、 New Horizon Health、 iStat Biomedical Co., Ltd、 GRAIL、 Laboratory For Advanced Medicine Inc、 Genetron Health、 Berry Oncology ************************************************************* ・調査・分析レポートの概要 早期がん検診製品市場の定義 市場セグメント 世界の早期がん検診製品市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の早期がん検診製品市場規模 世界の早期がん検診製品市場規模：2021年 VS 2028年 世界の早期がん検診製品市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの早期がん検診製品の売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の早期がん検診製品製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：単一がん、汎がん 早期がん検診製品のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、クリニック、その他 早期がん検診製品の用途別グローバル売上・予測 ・地域別市場分析 地域別早期がん検診製品市場規模 2021年と2028年 地域別早期がん検診製品売上・予測 北米市場 - アメリカの早期がん検診製品市場規模2017年-2028年 - カナダの早期がん検診製品市場規模2017年-2028年 - メキシコの早期がん検診製品市場規模2017年-2028年 ヨーロッパ市場 - ドイツの早期がん検診製品市場規模2017年-2028年 - フランスの早期がん検診製品市場規模2017年-2028年 - イギリスの早期がん検診製品市場規模2017年-2028年 - イタリアの早期がん検診製品市場規模2017年-2028年 - ロシアの早期がん検診製品市場規模2017年-2028年 アジア市場 - 中国の早期がん検診製品市場規模2017年-2028年 - 日本の早期がん検診製品市場規模2017年-2028年 - 韓国の早期がん検診製品市場規模2017年-2028年 - 東南アジアの早期がん検診製品市場規模2017年-2028年 - インドの早期がん検診製品市場規模2017年-2028年 南米市場 - ブラジルの早期がん検診製品市場規模2017年-2028年 - アルゼンチンの早期がん検診製品市場規模2017年-2028年 中東・アフリカ市場 - トルコの早期がん検診製品市場規模2017年-2028年 - イスラエルの早期がん検診製品市場規模2017年-2028年 - サウジアラビアの早期がん検診製品市場規模2017年-2028年 - UAEの早期がん検診製品市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） EXACT Sciences Corporation、 Epigenomics AG、 Abbott Laboratories、 Genomictree、 oncgnostics GmbH、 Qiagen、 New Horizon Health、 iStat Biomedical Co., Ltd、 GRAIL、 Laboratory For Advanced Medicine Inc、 Genetron Health、 Berry Oncology ... |
Tumors are divided into benign tumors and malignant tumors. Cancer is a type of malignant tumor. Cancers mainly come from epithelial tissues, such as breast cancer, oral cancer, liver cancer and so on. Cancer screening is carried out between the “malignant tumor budding” and “malignant tumor activity” window periods.
This report contains market size and forecasts of Early Cancer Screening Products in Global, including the following market information:
Global Early Cancer Screening Products Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Early Cancer Screening Products market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single Cancer Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Early Cancer Screening Products include EXACT Sciences Corporation, Epigenomics AG, Abbott Laboratories, Genomictree, oncgnostics GmbH, Qiagen, New Horizon Health, iStat Biomedical Co., Ltd and GRAIL, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Early Cancer Screening Products companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Early Cancer Screening Products Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Early Cancer Screening Products Market Segment Percentages, by Type, 2021 (%)
Single Cancer
Pan Cancer
Global Early Cancer Screening Products Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Early Cancer Screening Products Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Early Cancer Screening Products Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Early Cancer Screening Products Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Early Cancer Screening Products revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Early Cancer Screening Products revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
EXACT Sciences Corporation
Epigenomics AG
Abbott Laboratories
Genomictree
oncgnostics GmbH
Qiagen
New Horizon Health
iStat Biomedical Co., Ltd
GRAIL
Laboratory For Advanced Medicine Inc
Genetron Health
Berry Oncology
1 Introduction to Research & Analysis Reports
1.1 Early Cancer Screening Products Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Early Cancer Screening Products Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Early Cancer Screening Products Overall Market Size
2.1 Global Early Cancer Screening Products Market Size: 2021 VS 2028
2.2 Global Early Cancer Screening Products Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Early Cancer Screening Products Players in Global Market
3.2 Top Global Early Cancer Screening Products Companies Ranked by Revenue
3.3 Global Early Cancer Screening Products Revenue by Companies
3.4 Top 3 and Top 5 Early Cancer Screening Products Companies in Global Market, by Revenue in 2021
3.5 Global Companies Early Cancer Screening Products Product Type
3.6 Tier 1, Tier 2 and Tier 3 Early Cancer Screening Products Players in Global Market
3.6.1 List of Global Tier 1 Early Cancer Screening Products Companies
3.6.2 List of Global Tier 2 and Tier 3 Early Cancer Screening Products Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type – Global Early Cancer Screening Products Market Size Markets, 2021 & 2028
4.1.2 Single Cancer
4.1.3 Pan Cancer
4.2 By Type – Global Early Cancer Screening Products Revenue & Forecasts
4.2.1 By Type – Global Early Cancer Screening Products Revenue, 2017-2022
4.2.2 By Type – Global Early Cancer Screening Products Revenue, 2023-2028
4.2.3 By Type – Global Early Cancer Screening Products Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Early Cancer Screening Products Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Early Cancer Screening Products Revenue & Forecasts
5.2.1 By Application – Global Early Cancer Screening Products Revenue, 2017-2022
5.2.2 By Application – Global Early Cancer Screening Products Revenue, 2023-2028
5.2.3 By Application – Global Early Cancer Screening Products Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region – Global Early Cancer Screening Products Market Size, 2021 & 2028
6.2 By Region – Global Early Cancer Screening Products Revenue & Forecasts
6.2.1 By Region – Global Early Cancer Screening Products Revenue, 2017-2022
6.2.2 By Region – Global Early Cancer Screening Products Revenue, 2023-2028
6.2.3 By Region – Global Early Cancer Screening Products Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country – North America Early Cancer Screening Products Revenue, 2017-2028
6.3.2 US Early Cancer Screening Products Market Size, 2017-2028
6.3.3 Canada Early Cancer Screening Products Market Size, 2017-2028
6.3.4 Mexico Early Cancer Screening Products Market Size, 2017-2028
6.4 Europe
6.4.1 By Country – Europe Early Cancer Screening Products Revenue, 2017-2028
6.4.2 Germany Early Cancer Screening Products Market Size, 2017-2028
6.4.3 France Early Cancer Screening Products Market Size, 2017-2028
6.4.4 U.K. Early Cancer Screening Products Market Size, 2017-2028
6.4.5 Italy Early Cancer Screening Products Market Size, 2017-2028
6.4.6 Russia Early Cancer Screening Products Market Size, 2017-2028
6.4.7 Nordic Countries Early Cancer Screening Products Market Size, 2017-2028
6.4.8 Benelux Early Cancer Screening Products Market Size, 2017-2028
6.5 Asia
6.5.1 By Region – Asia Early Cancer Screening Products Revenue, 2017-2028
6.5.2 China Early Cancer Screening Products Market Size, 2017-2028
6.5.3 Japan Early Cancer Screening Products Market Size, 2017-2028
6.5.4 South Korea Early Cancer Screening Products Market Size, 2017-2028
6.5.5 Southeast Asia Early Cancer Screening Products Market Size, 2017-2028
6.5.6 India Early Cancer Screening Products Market Size, 2017-2028
6.6 South America
6.6.1 By Country – South America Early Cancer Screening Products Revenue, 2017-2028
6.6.2 Brazil Early Cancer Screening Products Market Size, 2017-2028
6.6.3 Argentina Early Cancer Screening Products Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Early Cancer Screening Products Revenue, 2017-2028
6.7.2 Turkey Early Cancer Screening Products Market Size, 2017-2028
6.7.3 Israel Early Cancer Screening Products Market Size, 2017-2028
6.7.4 Saudi Arabia Early Cancer Screening Products Market Size, 2017-2028
6.7.5 UAE Early Cancer Screening Products Market Size, 2017-2028
7 Players Profiles
7.1 EXACT Sciences Corporation
7.1.1 EXACT Sciences Corporation Corporate Summary
7.1.2 EXACT Sciences Corporation Business Overview
7.1.3 EXACT Sciences Corporation Early Cancer Screening Products Major Product Offerings
7.1.4 EXACT Sciences Corporation Early Cancer Screening Products Revenue in Global Market (2017-2022)
7.1.5 EXACT Sciences Corporation Key News
7.2 Epigenomics AG
7.2.1 Epigenomics AG Corporate Summary
7.2.2 Epigenomics AG Business Overview
7.2.3 Epigenomics AG Early Cancer Screening Products Major Product Offerings
7.2.4 Epigenomics AG Early Cancer Screening Products Revenue in Global Market (2017-2022)
7.2.5 Epigenomics AG Key News
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Corporate Summary
7.3.2 Abbott Laboratories Business Overview
7.3.3 Abbott Laboratories Early Cancer Screening Products Major Product Offerings
7.3.4 Abbott Laboratories Early Cancer Screening Products Revenue in Global Market (2017-2022)
7.3.5 Abbott Laboratories Key News
7.4 Genomictree
7.4.1 Genomictree Corporate Summary
7.4.2 Genomictree Business Overview
7.4.3 Genomictree Early Cancer Screening Products Major Product Offerings
7.4.4 Genomictree Early Cancer Screening Products Revenue in Global Market (2017-2022)
7.4.5 Genomictree Key News
7.5 oncgnostics GmbH
7.5.1 oncgnostics GmbH Corporate Summary
7.5.2 oncgnostics GmbH Business Overview
7.5.3 oncgnostics GmbH Early Cancer Screening Products Major Product Offerings
7.5.4 oncgnostics GmbH Early Cancer Screening Products Revenue in Global Market (2017-2022)
7.5.5 oncgnostics GmbH Key News
7.6 Qiagen
7.6.1 Qiagen Corporate Summary
7.6.2 Qiagen Business Overview
7.6.3 Qiagen Early Cancer Screening Products Major Product Offerings
7.6.4 Qiagen Early Cancer Screening Products Revenue in Global Market (2017-2022)
7.6.5 Qiagen Key News
7.7 New Horizon Health
7.7.1 New Horizon Health Corporate Summary
7.7.2 New Horizon Health Business Overview
7.7.3 New Horizon Health Early Cancer Screening Products Major Product Offerings
7.7.4 New Horizon Health Early Cancer Screening Products Revenue in Global Market (2017-2022)
7.7.5 New Horizon Health Key News
7.8 iStat Biomedical Co., Ltd
7.8.1 iStat Biomedical Co., Ltd Corporate Summary
7.8.2 iStat Biomedical Co., Ltd Business Overview
7.8.3 iStat Biomedical Co., Ltd Early Cancer Screening Products Major Product Offerings
7.8.4 iStat Biomedical Co., Ltd Early Cancer Screening Products Revenue in Global Market (2017-2022)
7.8.5 iStat Biomedical Co., Ltd Key News
7.9 GRAIL
7.9.1 GRAIL Corporate Summary
7.9.2 GRAIL Business Overview
7.9.3 GRAIL Early Cancer Screening Products Major Product Offerings
7.9.4 GRAIL Early Cancer Screening Products Revenue in Global Market (2017-2022)
7.9.5 GRAIL Key News
7.10 Laboratory For Advanced Medicine Inc
7.10.1 Laboratory For Advanced Medicine Inc Corporate Summary
7.10.2 Laboratory For Advanced Medicine Inc Business Overview
7.10.3 Laboratory For Advanced Medicine Inc Early Cancer Screening Products Major Product Offerings
7.10.4 Laboratory For Advanced Medicine Inc Early Cancer Screening Products Revenue in Global Market (2017-2022)
7.10.5 Laboratory For Advanced Medicine Inc Key News
7.11 Genetron Health
7.11.1 Genetron Health Corporate Summary
7.11.2 Genetron Health Business Overview
7.11.3 Genetron Health Early Cancer Screening Products Major Product Offerings
7.11.4 Genetron Health Early Cancer Screening Products Revenue in Global Market (2017-2022)
7.11.5 Genetron Health Key News
7.12 Berry Oncology
7.12.1 Berry Oncology Corporate Summary
7.12.2 Berry Oncology Business Overview
7.12.3 Berry Oncology Early Cancer Screening Products Major Product Offerings
7.12.4 Berry Oncology Early Cancer Screening Products Revenue in Global Market (2017-2022)
7.12.5 Berry Oncology Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer